Literature DB >> 16210935

Fifteen-year risk of major coronary events predicted by Holter ST-monitoring in asymptomatic middle-aged men.

Martin Stagmo1, Steen Juul-Möller, Bo Israelsson.   

Abstract

BACKGROUND: Ambulatory electrocardiogram monitoring (Holter) with ST-analysis as a measure of myocardial ischemia has in populations with coronary heart disease been shown to predict major coronary events: death, myocardial infarction or coronary revascularization. There has, however, been conflicting evidence regarding the usefulness of this technique in identification of healthy subjects with increased risk for coronary heart disease. The aim of this study was to assess if Holter monitoring with ST-analysis could be used to predict future major coronary events in asymptomatic middle-aged men with a defined aggregation of traditional risk factors for coronary heart disease.
METHODS: One hundred and fifty-five asymptomatic participants from the city of Malmö, Sweden, with known levels of conventional cardiovascular risk factors underwent Holter monitoring for analysis of transient ST-segment depression at the age of 55 years. Fifteen years after the Holter monitoring, hospital records, diagnosis and death registries were revisited for major coronary events.
RESULTS: An ST-segment depression of 1 mm or greater (0.1 mV) was considered significant for myocardial ischemia and was found in 54 of the 155 men. There were no significant differences in risk factors in the two groups at baseline. The 15-year incidence of a first major coronary event was significantly higher in men with ST-segment depression (39%) than in men without ST-segment depression (20%) (P<0.015). A Holter electrocardiogram could predict future major coronary events with a positive and negative predictive value of 35 and 80%, respectively.
CONCLUSIONS: Holter monitoring can be used as a complement to conventional risk factor evaluation in deciding whether or not to treat risk factors for CHD in asymptomatic subjects.

Entities:  

Mesh:

Year:  2005        PMID: 16210935     DOI: 10.1097/01.hjr.0000176511.22284.c1

Source DB:  PubMed          Journal:  Eur J Cardiovasc Prev Rehabil        ISSN: 1741-8267


  5 in total

1.  Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.

Authors:  Merete Vaage-Nilsen; Dorte L Nielsen; Anne Dyhl-Polk; Morten Schou; Kirsten K Vistisen; Anne-Sophie Sillesen; Eva Serup-Hansen; Jens Faber; Tobias W Klausen; Stig E Bojesen
Journal:  Oncologist       Date:  2020-10-07

2.  Risk factors for silent myocardial ischemia in patients with well-controlled essential hypertension.

Authors:  Domenico Rendina; Renato Ippolito; Gianpaolo De Filippo; Riccardo Muscariello; Daniela De Palma; Silvana De Bonis; Michele Schiano di Cola; Domenico Benvenuto; Maurizio Galderisi; Pasquale Strazzullo; Ferruccio Galletti
Journal:  Intern Emerg Med       Date:  2016-08-26       Impact factor: 3.397

3.  A Novel Point-of-Care Smartphone Based System for Monitoring the Cardiac and Respiratory Systems.

Authors:  Kwanghyun Sohn; Faisal M Merchant; Omid Sayadi; Dheeraj Puppala; Rajiv Doddamani; Ashish Sahani; Jagmeet P Singh; E Kevin Heist; Eric M Isselbacher; Antonis A Armoundas
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

4.  ST segment depression in hypertensive patients: a comparison of exercise test versus Holter ECG.

Authors:  Sakir Uen; Rolf Fimmers; Burkhard Weisser; Johannes Baulmann; Osman Balta; Georg Nickenig; Thomas Mengden
Journal:  Vasc Health Risk Manag       Date:  2008

5.  Early morning surge and dipping status of blood pressure: are these of predictive value for silent myocardial ischemia?

Authors:  Sakir Uen; Siamak Asghari; Georg Nickenig; Thomas Mengden
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-07       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.